The effect of chamomile consumption on glycemic markers in humans and animals: a systematic review and meta-analysis.
J Diabetes Metab Disord
; 23(1): 189-198, 2024 Jun.
Article
en En
| MEDLINE
| ID: mdl-38932814
ABSTRACT
Purpose:
The use of natural and herbal products as alternative therapies, in conjunction with blood glucose-lowering medications, is on the rise for patients with diabetes. Our objective was to conduct a systematic review and comprehensive meta-analysis of both human and animal models to investigate the impact of chamomile consumption on glycemic control.Methods:
A systematic search was conducted on all published papers from January 1990 up to January 2022 via Scopus, PubMed/Medline, Google Scholar, and ISI Web of Science. Human and animal articles evaluating the effect of chamomile on serum glycemic markers were included. We used the random-effects model to establish the pooled effect size. The dose-dependent effect was also assessed.Results:
Overall, 4 clinical trials on human and 8 studies on animals met the inclusion criteria. With regard to RCTs, a favorable effect of chamomile consumption on serum fasting blood glucose (Standardized Mean Differences (SMD) -0.65, 95% CI -1.00, -0.29, P < 0.001; I2 = 0%) and hemoglobin A1C (HbA1C) levels (SMD -0.90, 95% CI -1.39, -0.40, P < 0.001; I2 = 45.4%) was observed. Considering animal studies, consumption of chamomile extracts significantly reduced serum blood glucose (SMD -4.37, 95% CI -5.76, -2.98, P < 0.001; I2 = 61.2%). Moreover, each 100 mg/d increase in chamomile extract intervention resulted in a significantly declined blood glucose concentrations (MD -54.35; 95% CI -79.77, -28.93, P < 0.001; I2 = 94.8).Conclusion:
The current meta-analysis revealed that chamomile consumption could exert favorable effects on serum blood glucose and HbA1C. However, additional randomized controlled trials are needed to further confirm these findings. Supplementary Information The online version contains supplementary material available at 10.1007/s40200-023-01345-8.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
J Diabetes Metab Disord
Año:
2024
Tipo del documento:
Article
País de afiliación:
Irán